Together Ending Asplenia Mortality

What is Asplenia?

IT IS THE ABSENCE OF A SPLEEN

Isolated Congenital Asplenia (ICA) is a birth defect in which one of the following occurs:

  • there is no spleen
  • there is only a splenic remnant
  • a spleen is present but non-functioning

IT IS A PRIMARY IMMUNODEFICIENCY

ICA causes life threatening infections because without the spleen there is not an adequate defense against encapsulated bacteria. 

THE SILENT KILLER

Although rare, ICA is severely underdiagnosed as it is usually only discovered at autopsy after a child has died suddenly from sepsis.

Our Mission

INCREASE AWARENESS

Currently the only organization in the world focused on Isolated Congenital Asplenia, T.E.A.M. 4 Travis will draw attention to this rare and deadly disease.

FUNDRAISING

T.E.A.M. 4 Travis fundraising efforts are directed to further research of the genetic mutation that causes ICA, development of tests to diagnose the disease and creation of effective treatment plans.

SCIENTIFIC KNOWLEDGE

T.E.A.M. 4 Travis  embraces relationships with the world's leading researchers who are passionately dedicated to preventing childhood death from ICA.

EDUCATION FOR THE MEDICAL COMMUNITY

T.E.A.M. 4 Travis aims to bring increased knowledge of ICA to medical and nursing school curriculum.

FAMILY EDUCATION AND SUPPORT

T.E.A.M. 4 Travis aims to provide information about ICA research to affected families. Once a test is developed, T.E.A.M. 4 Travis would provide patient education for children and their families living with ICA.

TRAVIS' LEGACY OF LOVE

To ensure Travis' exuberant love of life will carry on forever, by ending asplenia mortality.

Our Partners

image104
image105

Together ending asplenia mortaltiy

Your generous donations will allow us to help increase awareness and fund ongoing medical research to develop ways to diagnose, treat and ultimately prevent Asplenia from taking one more child's life. 

We are a 501(c)(3) organization.

Pay with PayPal or a debit/credit card

Stay in Touch

Sign up to hear about new research on this genetic disease and our charitable organization's upcoming events.